These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3582385)

  • 1. Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.
    Serruys PW; Deckers JW; Luijten HE; Reiber JH; Tijssen JG; Chadha D; Hugenholtz PG
    Eur Heart J; 1987 Mar; 8(3):263-70. PubMed ID: 3582385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
    Schulz W; Wendt T; Scherer D; Kober G
    Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
    Sobolski J; Vandermoten P; Stoupel E; Berkenboom G; Degre S
    Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine.
    Schulz W; Kober G; Bernauer R; Kaltenbach M
    Am Heart J; 1985 Mar; 109(3 Pt 2):694-9. PubMed ID: 3838406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1).
    Drobinski G; Montalescot G
    Eur Heart J; 1990 May; 11(5):472-5. PubMed ID: 2112998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteries.
    Dubois-Rande JL; Dupouy P; Geschwind H; Castaigne A; Adnot S
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):462-7. PubMed ID: 7504139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-ischemic effects of SIN-1, a molsidomine metabolite, during coronary angioplasty and antiplatelet effects in humans].
    Darius H; Erbel E; Schmucker B; Reusch U; Meyer J
    Presse Med; 1988 May; 17(20):1033-6. PubMed ID: 2969099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of intracoronary injection of SIN-1 on vasoconstriction of epicardial arteries induced by acetylcholine].
    Dubois-Randé JL; Adnot S; Dupouy P; Castaigne A; Geschwind H
    Arch Mal Coeur Vaiss; 1993 Jun; 86(6):881-7. PubMed ID: 8274060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilatory action after nicorandil: a quantitative angiographic study.
    Suryapranata H; Serruys PW
    Am J Cardiol; 1989 Jun; 63(21):80J-85J. PubMed ID: 2525332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and chronic effects of molsidomine in therapeutic coronary angioplasty].
    Darius H; Erbel R; Rupprecht HJ; Pop T; Meyer J
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():23-6. PubMed ID: 2185404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?
    Jost S; Nolte CW; Sturm M; Hausleiter J; Hausmann D
    Int J Card Imaging; 1998 Dec; 14(6):357-72. PubMed ID: 10453390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-induced angina alleviated by intracoronary SIN-1.
    Berkenboom GM; Unger P; Jottrand M; Loiseau J; Pype F; Degre SG
    Cardiology; 1987; 74(6):427-35. PubMed ID: 3435906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective and safe dose of intracoronary nicorandil in man.
    Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
    Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducible uniform coronary vasomotor tone with nitrocompounds: prerequisite of quantitative coronary angiographic trials.
    Jost S; Rafflenbeul W; Reil GH; Gulba D; Knop I; Hecker H; Lichtlen PR
    Cathet Cardiovasc Diagn; 1990 Jul; 20(3):168-73. PubMed ID: 2114218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of coronary vasomotor tone with intracoronary nitroglycerin.
    Jost S; Sturm M; Hausmann D; Lippolt P; Lichtlen PR
    Am J Cardiol; 1996 Jul; 78(1):120-3. PubMed ID: 8712104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
    Münzel T; Kurz S; Heitzer T; Luhmann C; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900
    [No Abstract]   [Full Text] [Related]  

  • 18. [SIN-1 in intracoronary administration].
    Schulz W
    Presse Med; 1988 May; 17(20):1027-32. PubMed ID: 2969098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic response to intracoronary injection of a vasodilator during coronary angiography. A randomized comparative study of trinitrin and linsidomin ].
    Chevalier B; Lancelin B
    Arch Mal Coeur Vaiss; 1991 Sep; 84(9):1345-51. PubMed ID: 1958119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasodilation with nitrocompounds--is there a maximum?
    Jost S; Reil G; Knop I; Rafflenbeul W; Auricchio A; Frombach R; Gulba D; Hecker H; Lichtlen P
    Z Kardiol; 1989; 78 Suppl 2():38-40; discussion 64-7. PubMed ID: 2511691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.